Adverum Biotechnologies, Inc.
看多

time to add target 2.25

48
time to add target 2.25 stoploss 1.13..Adverum is moving forward with its eye disease gene therapy that caused headaches in April 2021, but is doing so with fewer staff on board.

The biotech is laying off 78 employees, or about 38% of its workforce, in order to conserve cash and keep the lights on into 2025, according to an SEC filing.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。